“Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s46. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/995.